background

Engage With Us

Our Approach

Our Approach

Royalty Pharma has over 150+ years of investment experience working directly with research institutions and life science companies.

Ways to Work with Us

Royalty Monetization

ROYALTY MONETIZATION

Our strategy is simple: we acquire royalty interests in leading pharmaceutical and biotechnology products and hold these interests as part of our diversified portfolio.

R&D

R&D PARTNERSHIPS

Royalty Pharma works with drug developers to invest directly in late-stage clinical trials across all therapeutic areas. We prioritize alignment with our partners throughout the pharmaceutical life cycle by sharing in clinical development, regulatory approval and commercialization.

!!!ALT

M&A

We take a flexible approach to acquisitions and in-licensing transactions. Allowing companies to focus their resources on strategic assets, Royalty Pharma is the ideal partner for biopharma M&A.